Dividend-adjusted total return · S&P 500 uses VOO · Dec 31, 2025 – Nov 3, 2026FTXHS&P 500 · VOO
First Trust Nasdaq Pharmaceuticals ETFFTXH
$43.87
0.0% last session
+33.8% YTD
Data as of 11/3/20264:00 PM ET · End-of-day
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | 0.0% | +7.6% | +11.4% | +33.8% | +46.6% | +91.2% | +80.4% | +142.9% |
| Peer average | +0.6% | +4.0% | +6.1% | +21.0% | +29.0% | +81.2% | +28.9% | — |
| S&P 500 · VOO | +0.3% | −2.6% | −1.7% | +11.5% | +11.9% | +90.9% | +77.5% | — |
Key Statistics
Open all fund facts →- AUM
- $1.2B
- Expense ratio
- 0.60%
- Distribution yield
- 0.7%
- NAV
- $43.83
- Volume
- 138K
- Avg. volume 30D
- 263K
- High today
- $44.28
- Low today
- $43.87
- Previous close
- $43.89
- 52-week high
- $44.78
- 52-week low
- $29.85
- Our risk indicator
- 4/5
FTXH in One Breath
FTXH Among Health Care ETFs
YTDEnd-of-day Nov 4, 2026 · 33 Health care ETFs by YTD
$10,000 in FTXH
5Y$10,000 in FTXH became
$18,039
In the S&P 500 (VOO)
$17,749
Total return, dividends in · Oct 26, 2021 – Nov 3, 2026 · S&P 500 uses VOO
FTXH’s Top Holdings
TodayLLYEli Lilly and Company8.2%ABBV7.7%PFE7.2%JNJ6.9%MRK6.8%BIIB3.9%GILD3.9%REGN3.9%VTRS3.9%AMGN3.6%UTHR3.5%ZTS3.5%VRTX3.4%INCY3.2%BMY3.1%EXEL2.6%JAZZ2.3%ILMN1.8%HALO1.8%MEDP1.5%CRL1.2%NBIX28 more
LLYEli Lilly and Company8.2%ABBV7.7%PFE7.2%JNJ6.9%MRK6.8%BIIB3.9%GILD3.9%REGN3.9%VTRS3.9%AMGN3.6%UTHRZTS38 more
Drug Manufacturers - GeneralBiotechnologyDrug Manufacturers - SpecialtyMedical - Diagnostics
First Trust FTXH · 50 holdings · tile size = share of the fund · as of Nov 3, 2026
What FTXH Holds
TodayDrug Manufacturers - General51.4%
LLY 8.2 · ABBV 7.7 · PFE 7.2 · JNJ 6.9 · MRK 6.8 · BIIB 3.9 · GILD 3.9
Biotechnology33.3%
REGN 3.9 · UTHR 3.5 · VRTX 3.4 · INCY 3.2 · EXEL 2.6 · JAZZ 2.3 · HALO 1.8
Drug Manufacturers - Specialty & Generic9.5%
VTRS 3.9 · ZTS 3.5 · ELAN 1.1 · AMRX · ALKS
Medical - Diagnostics & Research5.0%
ILMN 1.8 · MEDP 1.5 · CRL 1.2 · GH
Medical - Pharmaceuticals0.6%
CORT · LQDA
First Trust FTXH · share of the fund by industry · as of Nov 3, 2026
Eli’s Share of FTXH
Today8.2%
$82 of every $1,000 in FTXH is Eli
Eli held by FTXH
$96.7M
First Trust FTXH · each square = $10 of $1,000 · as of Nov 3, 2026
FTXH’s Share of Health Care ETFs
Today1.1%
of the $109B in 39 Health care ETFs
$1.2B1.1%
$49.1B45.0%
$19.1B17.5%
$39.7B36.4%
Health care ETF AUM · Nov 4, 2026
FTXH Fee per $100 vs Peers
TodayExpense ratio · Health care peers · Nov 4, 2026
Inside FTXH
50 holdings · as of Nov 3, 2026FTXH
First Trust Nasdaq Pharmaceuticals ETF
TodayDrug Manufacturers - General51.4%LLY8.2%ABBV7.7%PFE7.2%JNJ6.9%MRK6.8%BIIB3.9%GILD3.9%AMGN3.6%BMY3.1%Biotechnology33.3%REGN3.9%UTHR3.5%VRTX3.4%INCY3.2%EXEL2.6%JAZZ2.3%HALO1.8%NBIXBMRNALNYMRNACAILGND16 moreDrug Manufacturers - Specialty9.5%VTRS3.9%ZTS3.5%ELANAMRXALKSMedical - Diagnostics5.0%ILMNMEDPCRLGH
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 8.22% |
| 2 | ABBV | AbbVie | 7.71% |
| 3 | PFE | Pfizer | 7.19% |
| 4 | JNJ | Johnson & Johnson | 6.89% |
| 5 | MRK | Merck & | 6.78% |
| 6 | BIIB | Biogen | 3.92% |
| 7 | GILD | Gilead Sciences | 3.91% |
| 8 | REGN | Regeneron Pharmaceuticals | 3.89% |
| 9 | VTRS | Viatris | 3.86% |
| 10 | AMGN | Amgen | 3.63% |
Drug Manufacturers - GeneralBiotechnologyDrug Manufacturers - SpecialtyMedical - DiagnosticsMedical - Pharmaceuticals
First Trust FTXH · current holdings by weight · as of Nov 3, 2026 · each tile is one holding · top 20 = 82.8%
How It Compares
FTXH
First Trust Nasdaq Pharmaceuticals ETF’s Peers
TodayHealth care peers · Today’s and past-year returns · as of Nov 4, 2026 · sorted by AUM
Head to Head
Put FTXH head to head with XLV →XLV vs FTXH
YTDYear to date
FTXH wins+13.4 pts
Past year
FTXH wins+16.9 pts
Fee
XLV winslower fee
Yield
XLV wins+0.7 pts
AUM
XLV41.7× more
2–2level
SPDR XLV and First Trust FTXH · year-to-date · as of Nov 4, 2026 · AUM not scored
FTXH vs VOO
YTDFTXH · First Trust Nasdaq Pharmaceuticals
+33.8%
VOO · S&P 500
+11.5%
Gap
22.2 pts
First Trust FTXH and Vanguard VOO · Today total return · as of Nov 4, 2026
FTXH vs Its Peer Average
YTDFTXHAvsBPeer average
1D0.0%+0.6%
1M+7.6%+4.0%
3M+11.4%+6.1%
YTD+33.8%+21.0%
1Y+46.6%+29.0%
3Y+91.2%+81.2%
5Y+80.4%+28.9%
6–1FTXH wins
38 Health care peers · each row scaled to its leader
The Details
FTXH
Risk
1Y4/5our risk indicator
CalmerBumpier
Volatility · 1Y17.72%
Deepest drop · 1Y−7.5%
Lowest point · 5Y−6.2%
52-week range
$43.87
$29.85−2.0% from the high$44.78
First Trust FTXH · past-year price moves · as of Nov 4, 2026
FTXH
Fund Facts
Today2016launched Sep 20
Tracks[…]
Exchange · CUSIPNASDAQ · 33738R837
StructureETF
Leverage1x
Cost on $10,000$60 a year
Go deeper
First Trust FTXH · fund facts · as of Nov 4, 2026
FTXH
Payouts by Year
11Y$0.0113per share, Sep 2026
Distribution yield0.7%
PaidEvery quarter
Latest ex-date · paidSep 24 · Sep 30, 2026
12 payouts added up$1.20 a share
First Trust FTXH · distributions by ex-date · 2016–2026
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
summary prospectus · SEC 497K ↗SEC reported portfolio · 2026-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2026-03-31 ↗SEC reported portfolio · 2025-12-31 ↗SEC reported portfolio · 2025-09-30 ↗SEC reported portfolio · 2025-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-03-31 ↗SEC reported portfolio · 2024-12-31 ↗SEC reported portfolio · 2024-09-30 ↗SEC reported portfolio · 2024-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-03-31 ↗SEC reported portfolio · 2023-12-31 ↗SEC reported portfolio · 2023-09-29 ↗SEC reported portfolio · 2023-06-30 ↗SEC reported portfolio · 2023-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2023-03-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2022-12-30 ↗
Trading & Liquidity
Net asset value$43.83
Premium / discount[…]
Median spread · 30D[…]
Volume today138K
Average volume · 30D263K
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.60%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$60.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 24, 2026 | Sep 30, 2026 | $0.0113 |
| Jun 25, 2026 | Jun 30, 2026 | $0.0920 |
| Mar 26, 2026 | Mar 31, 2026 | $0.0573 |
| Dec 12, 2025 | Dec 31, 2025 | $0.13 |
| Sep 25, 2025 | Sep 30, 2025 | $0.15 |
| Jun 26, 2025 | Jun 30, 2025 | $0.0892 |
| Mar 27, 2025 | Mar 31, 2025 | $0.0992 |
| Dec 13, 2024 | Dec 31, 2024 | $0.13 |
| Sep 26, 2024 | Sep 30, 2024 | $0.12 |
| Jun 27, 2024 | Jun 28, 2024 | $0.13 |
| Mar 21, 2024 | Mar 28, 2024 | $0.0676 |
| Dec 22, 2023 | Dec 29, 2023 | $0.12 |
Issuer contentFrom First TrustHear the strategy from the people behind FTXH.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →